Published

Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Gastrointestinal Endoscopy
Date: 2026-04-30
Source: OpenAlex
DOI: 10.1016/s0016-5107(26)04363-4
PubMed: Unavailable

Authors

Erin Mauney Juliana Zambrano Jenna Clukey Helen Burton-Murray Michael Datko Vitaly Napadow Braden Kuo Franklin King

Watch author

Topics and keywords

psilocybin Clinical Trial Inflammation Clinical Trial Medicine MEDLINE Internal medicine Physical therapy Irritable bowel syndrome Intensive care medicine Clinical trial Surgery Severity of illness Pilot trial Gastrointestinal motility and disorders Celiac Disease Research and Management Inflammatory Bowel Disease

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS2026-04-30

Related papers

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18 The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.govDrug Design Development and Therapy · 2024-03-31 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy · 2025-01-12 Supplemental Material for A Critical Evaluation of Psilocybin-Assisted Therapy Protocol Components From Clinical Trial Patients, Facilitators, and CaregiversPsychotherapy · 2024-12-31 Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and CodependencyContemporary Family Therapy · 2025-12-10 Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticityBiomedicine & Pharmacotherapy · 2025-10-29 Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in Psychiatry and Psychotherapy · 2024-12-31